Trials / Completed
CompletedNCT03484455
Study to Evaluate Performance of the Organ Recovery Systems LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant
A Prospective Randomized Multi-Center Study of the Use of the Organ Recovery Systems LifePort® Liver Transporter (LLT) System With Vasosol® as Compared to Static Cold Storage in Orthotopic Liver Transplants (Perfusion to Improve Liver Outcomes in Transplantation)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 142 (actual)
- Sponsor
- Organ Recovery Systems, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of hypothermic machine perfusion of livers to standard of care (static cold storage).
Detailed description
Prospective, randomized, multi-center study to show safe and effective use of whole liver preservation via hypothermic machine perfusion (HMP) as compared to livers preserved by static cold storage.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hypothermic machine perfusion | Organ Recovery Systems LifePort® Liver Transporter (LLT) System and Vasosol® Machine Perfusion Solution |
| DEVICE | Static cold storage | Static cold storage (standard of care) |
Timeline
- Start date
- 2019-04-03
- Primary completion
- 2022-07-12
- Completion
- 2022-07-12
- First posted
- 2018-03-30
- Last updated
- 2022-10-07
Locations
9 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03484455. Inclusion in this directory is not an endorsement.